148 PVR-related genes were confirmed to have prognostic value, and 6 of them (ALDH1L2, ANXA1, CERCAM, GNA12, GSDMB, and PLOD1) were used to establish a risk signature for predicting the OS of BLCA patients. The gene discussed is GNA12; the disease is bladder transitional cell carcinoma.